2022

Valentine Barassé et al.
Venomics survey of six myrmicine ants provides insights into the molecular and structural diversity of their peptide toxins
Insect Biochemistry and Molecular Biology 2022, vol. 151
doi: 10.1016/j.ibmb.2022.103876

Edmone Dewaeles et al.
Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects
Journal of Clinical Investigation 2022, vol. 132, issue 22
doi: 10.1172/jci152924

Edmone Dewaeles et al.
Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects
Journal of Clinical Investigation 2022, vol. 132, issue 22
doi: 10.1172/jci152924

Gaëlle Hayot et al.
Loss of autism-candidate CHD8 perturbs neural crest development and intestinal homeostatic balance
Life Science Alliance 2022, vol. 6, issue 1
doi: 10.26508/lsa.202201456

Tanya Stojkovic et al.
LAMA2-Related Muscular Dystrophy: The Importance of Accurate Phenotyping and Brain Imaging in the Diagnosis of LGMD
Journal of Neuromuscular Diseases 2022, vol. 10, issue 1
doi: 10.3233/jnd-221555

Juliana Pipoli da Fonseca et al.
Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysis
Scientific Reports 2022, vol. 12, issue 1
doi: 10.1038/s41598-022-23422-3

Sandra Garcés-Pastor et al.
High resolution ancient sedimentary DNA shows that alpine plant diversity is associated with human land use and climate change
Nature Communications 2022, vol. 13, issue 1
doi: 10.1038/s41467-022-34010-4

Julie Rebejac et al.
Meningeal macrophages protect against viral neuroinfection
Immunity 2022, vol. 55, issue 11
doi: 10.1016/j.immuni.2022.10.005

Kenza Nedara et al.
Relevance of the TRIAP1/p53 axis in colon cancer cell proliferation and adaptation to glutamine deprivation
Frontiers in Oncology 2022, vol. 12
doi: 10.3389/fonc.2022.958155

Estelle Colin et al.
OMIXCARE: OMICS technologies solved about 33% of the patients with heterogeneous rare neuro-developmental disorders and negative exome sequencing results and identified 13% additional candidate variants
Frontiers in Cell and Developmental Biology 2022, vol. 10
doi: 10.3389/fcell.2022.1021785